Cigarette‒E-cigarette Transitions and Respiratory Symptom Development.
Population Clinical
Likelihood Of Use
Berlowitz (2023)
Longitudinal transitions in adolescent polytobacco use across waves 1-4 of the Population Assessment of Tobacco and Health study.
Population Clinical
Likelihood Of Use
ALL
Blank (2023)
Transitions between cigarette, ENDS and dual use in adults in the PATH study (waves 1-4): multistate transition modelling accounting for complex survey design.
Population Clinical
Likelihood Of Use
Brouwer (2020)
The Impact of Menthol Cigarette Flavor in the U.S.: Cigarette and ENDS Transitions by Sociodemographic Group.
Population Clinical
Likelihood Of Use
Brouwer (2022)
Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of youth and adults in the PATH Study in 2015-2017 vs 2017-2019.
Population Clinical
Likelihood Of Use
Brouwer (2023)
Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial
Population Clinical
Likelihood Of Use
Current Users Switching From Tobacco To Ends
Bullen (2010)
Predictors of JUUL, other electronic nicotine delivery systems, and combustible tobacco initiation among Texas youth.
Population Clinical
Likelihood Of Use
Never Smokers Initiating Use Of ENDs
Case (2020)
Does e-cigarette experimentation increase the transition to daily smoking among young ever-smokers in France?
Population Clinical
Likelihood Of Use
ENDS To Tobacco
Chyderiotis (2020)
Descriptive Analysis of Transitions from Smoking to Electronic Nicotine Delivery System (ENDS) Use: A Daily Diary Investigation.
Population Clinical
Likelihood Of Use
Former Smokers Initating Use Of ENDS
Conner (2021)
Association of electronic cigarette vaping and subsequent smoking relapse among former smokers.
Population Clinical
Likelihood Of Use
Former Smokers Switching From ENDS To Tobacco
Dai (2019)